Literature DB >> 20697259

Tickborne infections in the southern United States.

Linda J Salinas1, Ronald A Greenfield, Susan E Little, Gene W Voskuhl.   

Abstract

Established and emerging tickborne infections are significant causes of human illness in the southern United States. Rocky Mountain spotted fever, human monocytic ehrlichiosis, human ewingii ehrlichiosis and tularemia are known pathogens in this geographic distribution. Rickettsia parkeri and novel ehrlichioses are more recently described tickborne infections reviewed in this article. An understanding of the tick vectors, pathogenesis, epidemiology, clinical presentation, diagnosis and treatment is useful for the clinician treating patients potentially infected with any of these pathogens. Prevention measures, the optimal method for removing an attached tick and current and future vaccine development conclude this review.

Entities:  

Mesh:

Year:  2010        PMID: 20697259     DOI: 10.1097/MAJ.0b013e3181e93817

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  15 in total

1.  Mixed cryoglobulinemia and secondary membranoproliferative glomerulonephritis associated with ehrlichiosis.

Authors:  Dawn J Caster; James T Summersgill; Paisit Paueksakon; Robert F Massung; Wun-Ju Shieh; Kenneth R McLeish
Journal:  CEN Case Rep       Date:  2014-03-08

Review 2.  Delayed anaphylaxis to red meat in patients with IgE specific for galactose alpha-1,3-galactose (alpha-gal).

Authors:  Scott P Commins; Thomas A E Platts-Mills
Journal:  Curr Allergy Asthma Rep       Date:  2013-02       Impact factor: 4.806

3.  Epidemiology of ehrlichiosis and anaplasmosis among American Indians in the United States, 2000-2007.

Authors:  Arianne M Folkema; Robert C Holman; F Scott Dahlgren; James E Cheek; Jennifer H McQuiston
Journal:  Am J Trop Med Hyg       Date:  2012-07-23       Impact factor: 2.345

4.  Identification of Francisella tularensis outer membrane protein A (FopA) as a protective antigen for tularemia.

Authors:  Anthony J Hickey; Karsten R O Hazlett; Girish S Kirimanjeswara; Dennis W Metzger
Journal:  Vaccine       Date:  2011-07-29       Impact factor: 3.641

Review 5.  Emerging Tick-Borne Diseases.

Authors:  Susan Madison-Antenucci; Laura D Kramer; Linda L Gebhardt; Elizabeth Kauffman
Journal:  Clin Microbiol Rev       Date:  2020-01-02       Impact factor: 26.132

6.  Seroprevalence of Ehrlichia canis, Ehrlichia chaffeensis and Ehrlichia ewingii in dogs in North America.

Authors:  Melissa J Beall; A Rick Alleman; Ed B Breitschwerdt; Leah A Cohn; C Guillermo Couto; Michael W Dryden; Lynn C Guptill; Cristina Iazbik; Stephen A Kania; Patty Lathan; Susan E Little; Alma Roy; Katherine A Sayler; Brett A Stillman; Elizabeth G Welles; Wendy Wolfson; Michael J Yabsley
Journal:  Parasit Vectors       Date:  2012-02-08       Impact factor: 3.876

Review 7.  Non-lyme tick-borne diseases: a neurological perspective.

Authors:  Navid Seraji-Bozorgzad; Alexandros C Tselis
Journal:  Curr Neurol Neurosci Rep       Date:  2013-10       Impact factor: 6.030

8.  Comparative speed of kill of sarolaner (Simparica™ Chewables) and fluralaner (Bravecto(®)) against induced infestations of Amblyomma americanum on dogs.

Authors:  Robert H Six; David R Young; Melanie R Myers; Sean P Mahabir
Journal:  Parasit Vectors       Date:  2016-07-18       Impact factor: 3.876

9.  Comparative speed of kill of sarolaner (Simparica) and afoxolaner (NexGard) against induced infestations of Rhipicephalus sanguineus s.l. on dogs.

Authors:  Robert H Six; David R Young; Susan J Holzmer; Sean P Mahabir
Journal:  Parasit Vectors       Date:  2016-02-19       Impact factor: 3.876

10.  Lyme borreliosis in human patients in Florida and Georgia, USA.

Authors:  Kerry L Clark; Brian Leydet; Shirley Hartman
Journal:  Int J Med Sci       Date:  2013-05-23       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.